Barker RA - Search Results

1

Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease.

Barker RA, Barrett J, Mason SL, Björklund A. Barker RA, et al. Lancet Neurol. 2013 Jan;12(1):84-91. doi: 10.1016/S1474-4422(12)70295-8. Lancet Neurol. 2013. PMID: 23237903 Review.

2

Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET.

Cools R, Stefanova E, Barker RA, Robbins TW, Owen AM. Cools R, et al. Among authors: barker ra. Brain. 2002 Mar;125(Pt 3):584-94. doi: 10.1093/brain/awf052. Brain. 2002. PMID: 11872615

3

Repairing the brain in Parkinson's disease: where next?

Barker RA. Barker RA. Mov Disord. 2002 Mar;17(2):233-41. doi: 10.1002/mds.10091. Mov Disord. 2002. PMID: 11921107 Review. No abstract available.

4

The heterogeneity of idiopathic Parkinson's disease.

Foltynie T, Brayne C, Barker RA. Foltynie T, et al. Among authors: barker ra. J Neurol. 2002 Feb;249(2):138-45. doi: 10.1007/pl00007856. J Neurol. 2002. PMID: 11985378 Review.

5

The potential for circuit reconstruction by expanded neural precursor cells explored through porcine xenografts in a rat model of Parkinson's disease.

Armstrong RJ, Hurelbrink CB, Tyers P, Ratcliffe EL, Richards A, Dunnett SB, Rosser AE, Barker RA. Armstrong RJ, et al. Among authors: barker ra. Exp Neurol. 2002 May;175(1):98-111. doi: 10.1006/exnr.2002.7889. Exp Neurol. 2002. PMID: 12009763

6

Transplantation of expanded neural precursor cells from the developing pig ventral mesencephalon in a rat model of Parkinson's disease.

Armstrong RJ, Tyers P, Jain M, Richards A, Dunnett SB, Rosser AE, Barker RA. Armstrong RJ, et al. Among authors: barker ra. Exp Brain Res. 2003 Jul;151(2):204-17. doi: 10.1007/s00221-003-1491-8. Epub 2003 Jun 3. Exp Brain Res. 2003. PMID: 12783147

7

Long-term hibernation of human fetal striatal tissue does not adversely affect its differentiation in vitro or graft survival: implications for clinical trials in Huntington's disease.

Hurelbrink CB, Tyers P, Armstrong RJ, Dunnett SB, Barker RA, Rosser AE. Hurelbrink CB, et al. Among authors: barker ra. Cell Transplant. 2003;12(7):687-95. doi: 10.3727/000000003108747307. Cell Transplant. 2003. PMID: 14653616 Free article.

8

The potential of GDNF as a treatment for Parkinson's disease.

Hurelbrink CB, Barker RA. Hurelbrink CB, et al. Among authors: barker ra. Exp Neurol. 2004 Jan;185(1):1-6. doi: 10.1016/j.expneurol.2003.09.018. Exp Neurol. 2004. PMID: 14697313 No abstract available.

9

The future of cell-based transplantation therapies for neurodegenerative disorders.

Lazic SE, Barker RA. Lazic SE, et al. Among authors: barker ra. J Hematother Stem Cell Res. 2003 Dec;12(6):635-42. doi: 10.1089/15258160360732669. J Hematother Stem Cell Res. 2003. PMID: 14977473 Review.

10

Modern therapeutic approaches in Parkinson's disease.

Lewis SJ, Caldwell MA, Barker RA. Lewis SJ, et al. Among authors: barker ra. Expert Rev Mol Med. 2003 Mar 28;5(10):1-20. doi: 10.1017/S1462399403006008. Expert Rev Mol Med. 2003. PMID: 14987395 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

623 results

Search Page